FEATURED COMPANIES
- Biological Industries
- Bio-Techne Corporation
- Kraeber & Co GmbH
- LGC Group
- Merck KGaA
- Proliant Biologicals
Global Bovine Serum Albumin Market to Reach $309.7 Million by 2027
Amid the COVID-19 crisis, the global market for Bovine Serum Albumin estimated at US$254.8 Million in the year 2020, is projected to reach a revised size of US$309.7 Million by 2027, growing at a CAGR of 2.8% over the period 2020-2027. Dry, one of the segments analyzed in the report, is projected to record 2.6% CAGR and reach US$183 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid segment is readjusted to a revised 3.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $74.9 Million, While China is Forecast to Grow at 2.7% CAGR
The Bovine Serum Albumin market in the U.S. is estimated at US$74.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$55.4 Million by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
Select Competitors (Total 42 Featured):
Amid the COVID-19 crisis, the global market for Bovine Serum Albumin estimated at US$254.8 Million in the year 2020, is projected to reach a revised size of US$309.7 Million by 2027, growing at a CAGR of 2.8% over the period 2020-2027. Dry, one of the segments analyzed in the report, is projected to record 2.6% CAGR and reach US$183 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid segment is readjusted to a revised 3.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $74.9 Million, While China is Forecast to Grow at 2.7% CAGR
The Bovine Serum Albumin market in the U.S. is estimated at US$74.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$55.4 Million by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
Select Competitors (Total 42 Featured):
- Belhealth Investment Partners, LLC
- Biological Industries
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Itoham Yonekyu Holdings Inc.
- Kraeber & Co GmbH
- LGC Group
- Merck KGaA
- Proliant Biologicals
- Promega Corporation
Frequently Asked Questions about the Global Market for Bovine Serum Albumin
What is the estimated value of the Global Market for Bovine Serum Albumin?
What is the growth rate of the Global Market for Bovine Serum Albumin?
What is the forecasted size of the Global Market for Bovine Serum Albumin?
Who are the key companies in the Global Market for Bovine Serum Albumin?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Biological Industries
- Bio-Techne Corporation
- Kraeber & Co GmbH
- LGC Group
- Merck KGaA
- Proliant Biologicals
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
1. MARKET OVERVIEW
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Belhealth Investment Partners, LLC
- Biological Industries
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Itoham Yonekyu Holdings Inc.
- Kraeber & Co GmbH
- LGC Group
- Merck KGaA
- Proliant Biologicals
- Promega Corporation
Note: Product cover images may vary from those shown